The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson’s one-shot coronavirus vaccine.
Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech’s two-shot vaccines.
- Unlike Moderna and Pfizer-BioNTech’s shots, the J&J vaccine can also be stored at refrigerator temperatures for three months, making it easier to transport.
- White House coronavirus coordinator Jeff Zients said on Wednesday that J&J will have 3 million to 4 million doses ready for distribution. Continue reading.